Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults-Reference-Cited by-同舟云学术

Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults

Published:2013-03-19 Issue:3 Volume:8 Page:e57726
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ogwang Caroline,Afolabi Muhammed,Kimani Domtila,Jagne Ya Jankey,Sheehy Susanne H.,Bliss Carly M.,Duncan Christopher J. A.,Collins Katharine A.,Garcia Knight Miguel A.,Kimani Eva,Anagnostou Nicholas A.,Berrie Eleanor,Moyle Sarah,Gilbert Sarah C.,Spencer Alexandra J.,Soipei Peninah,Mueller Jenny,Okebe Joseph,Colloca Stefano,Cortese Riccardo,Viebig Nicola K.,Roberts Rachel,Gantlett Katherine,Lawrie Alison M.,Nicosia Alfredo,Imoukhuede Egeruan B.,Bejon Philip,Urban Britta C.,Flanagan Katie L.,Ewer Katie J.,Chilengi Roma,Hill Adrian V. S.,Bojang Kalifa

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. WHO (2011) World Malaria Report. World Health Organisation.

2. Global malaria mortality between 1980 and 2010: a systematic analysis;CJ Murray;Lancet,2012

3. Malaria elimination: worthy, challenging, and just possible;P Das;Lancet,2010

4. From the circumsporozoite protein to the RTS, S/AS candidate vaccine;J Cohen;Hum Vaccin,2010

5. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children;ST Agnandji;N Engl J Med,2011

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. R21 malaria vaccine is protective against intradermal but not intravenousPlasmodium falciparumsporozoites in a randomized controlled human malaria infection study in Kenyan adults;2024-08-08

2. Malaria vaccine efficacy, safety, and community perception in Africa: a scoping review of recent empirical studies;Infection;2024-03-05

3. Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults;Med;2023-10

4. Superior antibody immunogenicity of a RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults;2023-04-20

5. Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections;Pharmaceuticals;2023-02-22